Pediatric Medicines: Global Markets

Report Code: PHM170B

Publish Date: Dec 2019

Publisher: BCC Publishing

Category: Pharmaceuticals

Customize This Report

EXPLORE OFFERS

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

The global pediatric market should grow from $92.6 billion in 2019 to reach $116.6 billion by 2024 at a compound annual growth rate (CAGR) of 4.7% for the period of 2019-2024.

Report Includes

  • 55 tables
  • An overview of the global markets for pediatric medicines within the pharmaceutical industry
  • Analyses of the global market trends, with data from 2018, estimates for 2019, and projections of compound annual growth rates (CAGRs) through 2024
  • Discussion on market drivers, off-label use, novel formulations and areas of unmet clinical need and emerging countries
  • Market analysis for therapeutic fields including neonates and paediatrics childhood cancers, CNS disorders, infectious diseases, immune inflammatory diseases, metabolic diseases, respiratory conditions, vaccinations
  • Regulatory environment and incentives for pediatric development
  • Profiles of major companies of the industry, including Abbott Laboratories, GlaxoSmithKline, Novartis AG, Sanofi and Vertex Pharmaceuticals Inc.

Report Scope

This new report on pediatric medicine will provide a brief overview on the current status of the industry and recent developments. It presents the changing environment in terms of new legislation and implementation of global pediatric plans. The report analyzes market trends and identifies key therapeutic and geographical challenges and rising opportunities in the developed and developing world. Finally, the report provides insights on how all stakeholders have an essential interest in prioritizing pediatric drug development targets and improving access to safe and effective medicines to children across the globe.

Analyst Credentials

Dr. C. L. Barton has more than 10 years’ practical pharmaceutical research experience with a leading pharmaceutical company and has served as a pan-European pharmaceutical analyst with a European bank. Dr. C.L. Barton Ltd. aims to provide independent, tailor-made, pharmaceutical thematic research to investment houses. Research reports combine independent scientific analysis with patient- and prescription-based models to forecast the potential sales growth of key developmental drugs and to isolate the key drivers within the pharmaceutical sector. For further information, visit www.pharmavision.co.uk.

Dr. Bianca Piachaud-Moustakis has more than 15 years of experience as a writer and research analyst specializing in pharmaceutical and healthcare intelligence and has worked for a number of market intelligence providers in the U.K. She has a broad range of writing experience ranging from international academic and practitioner journals, to producing market intelligence reports and short articles. Areas of specialization include pharmaceuticals, healthcare, diagnostics, drug delivery systems, emerging research and development technologies and pharmaceutical regulation.

Need a custom data table, graph, region, segment, companies or complete report? CUSTOMIZE NOW
Let us assist you! Our analysts are ready to tailor this report to your specific need. Talk to Our Analyst

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
. Title/Chapter NamePagesPrice Member Price
Full Report: Pediatric Medicines: Global Markets169 $2,500 Free
Chapter- 1: Introduction to Pediatric Medicine3Free
Chapter- 2: Summary and Highlights2$250Free
Chapter- 3: Pediatric Market Dynamics19$319Free
Chapter- 4: Regulation of Pediatric Medicine23$386Free
Chapter- 5: Challenges of Developing Pediatric Medicine22$369Free
Chapter- 6: Opportunities for Pediatric Medicine45$755Free
Chapter- 7: Future Outlook for Pediatric Medicine 13$218Free
Chapter- 8: Company Profiles 22$369Free
Chapter- 9: Appendix: Acronyms3$50Free
Published - Oct-2014| Analyst - Dr. Cheryl Lee Barton| Code - PHM170A

Report Highlights

The global market for pediatric medicines reached $80.7 billion in 2013 and should reach $83.6 billion in 2014. This market is expected to reach about $100.7 billion by 2019, registering a compound annual growth rate (CAGR) of 3.8% from 2014 to 2019.

Report Includes

  • An overview of the global market for pediatric medicines.
  • Analyses of global market trends, with data from 2013 and 2014, and projections of CAGRs through 2019.
  • Discussion on market drivers and inhibitors, and the area of unmet clinical need.
  • Information on the regulatory environment and impacts of government.
  • Details pertaining to the barriers to entry for pediatric medicines.
  • Market analysis for therapeutic fields including childhood cancers, CNS disorders, inflammatory diseases, metabolic diseases, respiratory conditions, vaccinations, and viral infections.

Related Reports

Pediatric Vaccines: Global Markets

Published - Oct 2022 | Publisher - BCC Publishing | Code - PHM265A

The global pediatric vaccines market should reach $34.5 billion by 2022 and more than $50.2 billion by 2027, with a compound annual growth rate (CAGR) of 7.8% during the forecast period of 2022-2027.

2021 Pharmaceuticals Research Review

Published - Apr 2022 | Publisher - Various Analysts | Code - PHM099G

BCC Research Market Report for generic drugs should grow from $411.6 billion in 2020 to $650.3 billion by 2025, at compound annual growth rate (CAGR) of 9.6%

Clinical Nutrition: Global Markets to 2025

Published - Jun 2021 | Publisher - BCC Publishing | Code - PHM198B

The global market for clinical nutrition is estimated to grow from $59.6 billion in 2020 to $75.4 billion by 2025, at a compound annual growth rate (CAGR) of 4.8% during the forecast period of 2020-2025.

Medication Adherence: Systems, Technologies and Global Markets

Published - Mar 2021 | Publisher - BCC Publishing | Code - PHM182B

The global market for medication adherence systems and technologies should grow from $3.5 billion in 2020 to $6.0 billion by 2025 with a compound annual growth rate (CAGR) of 11.4% for the period of 2020-2025.

Recent Reports

Drugs and Diagnostics for Hematological Disorders: Global Markets

Published - Aug 2024 | Publisher - BCC Publishing | Code - PHM116C

The global market for drugs and diagnostics for hematological disorders is expected to grow from $131.2 billion in 2024 and is projected to reach $189.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.6% during the forecast period of 2024 to 2029.

Gastrointestinal Therapeutics and Diagnostics: Technologies and Global Markets

Published - Apr 2024 | Publisher - BCC Publishing | Code - PHM046D

The global market for gastrointestinal (GI) therapeutics and diagnostics is expected to grow from $86.0 billion in 2023 and projected to reach $122.5 billion by the end of 2028, at a compound annual growth rate (CAGR) of 7.3% during the forecast period of 2023 to 2028.

Global Markets and Technologies for Advanced Drug Delivery Systems

Published - Mar 2024 | Publisher - BCC Publishing | Code - PHM006N

The global market for advanced drug delivery systems is expected to increase from $262.6 billion in 2023 to $359.1 billion by the end of 2028, with a compound annual growth rate (CAGR) of 6.5% during the forecast period of 2023-2028.

Prevention and Treatment of Prostate Cancer: Technologies and Global Markets

Published - Feb 2024 | Publisher - BCC Publishing | Code - PHM113C

The global market for prostate cancer care is expected to grow from $37.9 billion in 2023 to $56.4 billion by the end of 2028, at a compound annual growth rate (CAGR) of 8.3% from 2023 through 2028.

Chagas Disease: American trypanosomiasis Market

Published - Feb 2024 | Publisher - BCC Publishing | Code - PHM282A

The report provides detailed coverage of the Chagas Disease market. It analyzes the market trends and epidemiology of CD, and the regional markets of CD. It highlights the current market for CD and gives a detailed analysis of the competitive environment. The report depicts the complete scenario of Chagas Disease, types of parasites that cause human African trypanosomiasis (HAT) and its presence in various regions of the world.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Pediatric Medicines: Global Markets
Customize Report